Page 16 - JBO-211 (OUT-NOV-DEZ)
P. 16

JBO - Jornal Brasileiro de Oftalmologia              16            Nº 211 - Outubro/Novembro/Dezembro - 2025




            RETINA




      7. Conclusão
      A alta miopia deve ser compreendida como uma             para cada caso. Cabe ao oftalmologista generalista
      doença ocular crônica, com potencial para compro-        identificar  sinais  de  risco,  encaminhar  adequada-
      meter severamente a função visual. O diagnóstico         mente ao subespecialista e acompanhar esses pa-
      precoce e o uso racional de exames de imagem per-        cientes de forma longitudinal, visando preservar a
      mitem precisão no diagnóstico e tratamento correto       visão a longo prazo.




      Referências
      1. HOLDEN, B. A. et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology, [S.l.], v. 123, n. 5, p.
      1036–1042, 2016. DOI: https://doi.org/10.1016/j.ophtha.2016.01.006. Disponível em: https://www.aaojournal.org/article/S0161-6420(16)00025-7/fulltext.
      Acesso em: 21 out. 2025.
      2. OHNO-MATSUI, K. et al. Myopic maculopathy: new classification and its implications. Progress in Retinal and Eye Research, [S.l.], v. 39, p. 349–369,
      2015. DOI: https://doi.org/10.1016/j.preteyeres.2014.12.001. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S1350946214001006.
      Acesso em: 21 out. 2025.
      3. JONAS, J. B. et al. Pathophysiology of myopic maculopathy. Ophthalmology, [S.l.], v. 128, n. 5, p. 660–669, 2021. DOI: https://doi.org/10.1016/j.oph-
      tha.2020.10.005. Acesso em: 21 out. 2025.
      4. RUIZ-MEDRANO, J.; MONTERO, J. A. et al. High myopia and the retina: pathophysiology and management. Survey of Ophthalmology, [S.l.], v. 64, n.
      3, p. 352–366, 2019. DOI: https://doi.org/10.1016/j.survophthal.2018.12.003. Acesso em: 21 out. 2025.
      5. INTERNATIONAL MYOPIA INSTITUTE – IMI. Myopia and pathologic myopia update. Investigative Ophthalmology & Visual Science, [S.l.], v. 64, n. 6,
      art. 7, p. 1–30, 2023. DOI: https://doi.org/10.1167/iovs.64.6.7. Disponível em: https://iovs.arvojournals.org/article.aspx?articleid=2783966. Acesso em:
      21 out. 2025.
      6. CARLÀ, M. M. et al. Current advances in dome-shaped macula and associated conditions. Survey of Ophthalmology, [S.l.], v. 70, n. 1, p. 1–30, 2025.
      DOI:  https://doi.org/10.1016/j.survophthal.2025.09.004.  Disponível  em:  https://www.survophthal.com/article/S0039-6257(25)00123-4/fulltext.  Acesso
      em: 21 out. 2025.
      7. DEL FABBRO, S. et al. A new quantitative metric to assess dome-shaped macula. Translational Vision Science & Technology, [S.l.], v. 14, n. 8, art. 9, p.
      1–10, 2025. DOI: https://doi.org/10.1167/tvst.14.8.9. Disponível em: https://tvst.arvojournals.org/article.aspx?articleid=2783966. Acesso em: 21 out. 2025.
      8. JONAS, J. B.; PANDA-JONAS, S.; WEI, W. B.; XU, J.; WANG, Y. X. Prevalence and associations of dome-shaped maculas. Acta Ophthalmologica, [S.l.],
      v. 103, n. 2, p. 177–185, 2025. DOI: https://doi.org/10.1111/aos.16764. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/aos.16764. Acesso em:
      21 out. 2025.
      9. LI, M. et al. Clinical characteristics of dome-shaped macula in mild myopia and non-myopic eyes. Eye, [S.l.], v. 39, n. 12, p. 2211–2219, 2025. DOI:
      https://doi.org/10.1038/s41433-025-03756-8. Disponível em: https://www.nature.com/articles/s41433-025-03756-8. Acesso em: 21 out. 2025.
      10. OHNO-MATSUI, K. et al. PS-OCT imaging of scleral abnormalities in pathologic myopia. JAMA Ophthalmology, [S.l.], v. 142, n. 2, p. 183–190, 2024.
      DOI: https://doi.org/10.1001/jamaophthalmol.2023.5252. Acesso em: 21 out. 2025.
      11. TEDJA, M. S. et al. Genome-wide association meta-analysis identifies light-induced signaling as a driver for refractive error. Nature Genetics, [S.l.], v.
      50, n. 6, p. 834–848, 2018. DOI: https://doi.org/10.1038/s41588-018-0127-7. Disponível em: https://www.nature.com/articles/s41588-018-0127-7. Acesso
      em: 15 out. 2025.
      12. AVILA, M. P. et al. História natural da neovascularização coroidal na miopia degenerativa. Oftalmologia, [S.l.], v. 91, p. 1573–1581, 1984.
      13. SYAL, A. D.; SATAPATHY, J.; PANIGRAHI, P. K. Characteristics of myopic retinopathy and its awareness in adults: a hospital-based comparative study.
      BMC Ophthalmology, [S.l.], v. 25, art. 339, 2025. DOI: https://doi.org/10.1186/s12886-025-04175-9. Acesso em: 21 out. 2025.
      14. MORGAN, I. G.; OHNO-MATSUI, K.; SAW, S. M. Myopia. The Lancet, [S.l.], v. 379, n. 9827, p. 1739–1748, 5 maio 2012. DOI: https://doi.org/10.1016/
      S0140-6736(12)60272-4. Acesso em: 21 out. 2025.
      15. FANG, Y. et al. Macular Bruch’s membrane defect and dome-shaped macula in high myopia. PLOS ONE, [S.l.], v. 12, n. 6, p. e0178998, 2017. DOI:
      https://doi.org/10.1371/journal.pone.0178998. Acesso em: 21 out. 2025.
      16. ARAPI, I. et al. Considering photodynamic therapy as a therapeutic modality in selected cases of dome-shaped macula complicated by foveal serous
      retinal detachment. Ophthalmic Surgery, Lasers & Imaging Retina, [S.l.], v. 46, n. 2, p. 217–223, 2015. DOI: https://doi.org/10.3928/23258160-20150213-
      15. Acesso em: 21 out. 2025.
   11   12   13   14   15   16   17   18   19   20   21